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Surnrnary 
Contact hypersensitivity (CHS) is a T  cell-mediated response to hapten sensitization of the epi- 
dermis.  The roles of CD4 +  and CD8 + T  cells in CHS have remained unclear,  however,  as 
studies to define either subset as the T  cells mediating CHS have provided conflicting results. 
The goal of this study was to correlate the in vivo function ofCD4 + and CD8 + T  cells in CHS 
with  the  cytokines  produced  by  each  T  cell  population.  Antibody-mediated  depletion  of 
CD4 + T  cells before sensitization of BALB/c mice with 2,4-dinitrofluorobenzene (DNFB) or 
oxazolone (Ox) resulted in increased and prolonged CHS responses, indicating CD4 + T  cells as 
negative regulators of the response. Depletion ofCD8 + T  cells resulted in low or abrogated re- 
sponses, indicating CD8 + T  cells as the effector cells in CHS. Sensitization with DNFB or Ox 
induced lymph node cell populations of CD8 + T  cells producing interferon (IFN)-~/and no 
interleukin (I1) 4 or I1-10, and CD4 + T  cells producing I1-4 and I1-10 and no or little detectable 
IFN-~/. The polarized patterns of cytokine production were stimulated by culture of hapten- 
primed lymph node cells either on anti-T cell receptor antibody--coated wells or with semipu- 
rifled Langerhans cells  isolated from hapten-sensitized mice. Stimulation of cytokine produc- 
tion during culture ofhapten-primed CD4 + or CD8 + T  cells with Langerhans cells was hapten 
specific and restricted to class II or class I major histocompatibility complex, respectively. The 
induction  of the CD4 + and CD8 + T  cells producing the polarized patterns of cytokines was 
not restricted to BALB/c mice, as cells  from Ox sensitized C57B1/6  and B10.D2 mice pro- 
duced the same patterns. Collectively, these results expose the induction of two polarized and 
functionally opposing populations of T  cells by hapten sensitization to induce  CHS: IFN-~/- 
producing effector CD8 + T  cells and I1-4/II-10--producing CD4 + T  cells that negatively regu- 
late the response. 
C 
ontact  hypersensitivity  (CHS)  1 is  a  T  cell-mediated 
immune response in the epidermis to a reactive hap- 
ten covalently coupled to cell surface proteins (1,  2). Dur- 
ing the afferent or sensitization phase, the hapten-specific T 
cells mediating the CHS reaction are primed by Langerhans 
cells  (LC),  which  migrate from the  sensitized area of the 
epidermis  to  the  skin-draining  lymph  nodes  and  present 
hapten-MHC complexes to the peripheral T  cell repertoire 
(3-5). Subsequent contact or challenge with the hapten re- 
sults  in  cutaneous  infiltration  of the  primed  T  cells  and 
I  Abbreviations used in  this paper: CHS, contact hypersensitivity; DNFB, 
2,4-dinitrofluorobenzene;  DTH,  delayed-type hypersensitivity; LC, 
Langerhans cells; hpLC, hapten-presenting  Langerhans cells; LNC, lymph 
node cells; Ox, oxazolone. 
their activation to produce TNF-oe and IFN-~/, the cyto- 
kine mediators of the CHS reaction (6,  7). T  cell produc- 
tion  of proinflammatory cytokines is  followed by the  re- 
cruitment and infiltration of other inflammatory cells to the 
challenge  site  and  the  characteristic  edema,  peaking  at 
24-48  h  after challenge.  Although  CHS has been used in 
many laboratories as a model to examine T  cell responses to 
simple haptens presented in association with MHC  deter- 
minants,  studies  to  define  CD4 +  or CD8 +  T  cells  as the 
cellular mediators in  CHS  have yielded conflicting results. 
Results  from several laboratories  have  indicated  that  the 
CHS response is mediated by CD4 + T  cells and have led to 
the perception that CHS is equivalent to the  classical  de- 
layed-type hypersensitivity (DTH)  reaction,  which  is pri- 
marily  an  IFN-~/-producing  CD4 +  T  cell-mediated  ira- 
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(12), however, have indicated the ability of immune CD8 + 
T  cells to mediate CHS and the ability of immune CD4 + T 
cells  to  inhibit  the  response.  Overall,  these  studies  have 
used differences in the magnitude of CHS responses in the 
absence  or presence  of immune  CD4 +  and/or  CD8 +  T 
cells  to define the cellular components of the response. Al- 
though  CHS  is  actually  mediated  by  the  cytokines  pro- 
duced by primed T  cells,  cytokine production by hapten- 
specific  CD4 +  and  CD8 +  T  cells  in  CHS  has  remained 
largely undefined. 
During antigen priming, CD4 + T  cells develop from 11-2- 
producing precursor (i.e.,  Th0)  cells  into  one  of two  dis- 
tinct phenotypes ofcytokine-producing cells.  Thl cells pro- 
duce I1-2,  IFN-% and TNF-13, whereas Th2 cells produce 
I1-4, I1-5, 11-6, and I1-10 (for review see reference 13). The 
different patterns in cytokine production reflect the differ- 
ent  immune  functions  performed  by these  phenotypes  of 
CD4 +  T  cells.  DTH  reactions are mediated by Thl  cells, 
whereas  Th2 cells provide signals required for the genera- 
tion ofhumoral responses (11, 13, 14). An important aspect 
of the polarized production of cytokines is the regulation of 
Thl  responses by Th2 cytokines and vice versa. The mag- 
nitude  of DTH  reactions  is  inhibited  by  Th2  cytokines, 
particularly I1-4 and I1-10 (15,  16). Similarly, Th2 function 
and cytokine production are inhibited by the Thl  cytokine 
IFN-~ (17). Whereas antigen-primed CD8 + T  cells usually 
produce IFN-% in vitro studies have indicated that CD8 +, 
like  CD4 +, T  cells  can be skewed into  IFN-~/-producing 
(Tcl)  or I1-4/II-10-producing (Tc2)  cells by the  cytokine 
conditions present during antigen priming (18,  19). 
Similar  to results  observed in DTH,  reagents  either in- 
hibiting the induction of Thl  cells  or neutralizing Thl  cy- 
tokines result in decreased CHS responses. Treatment with 
either Th2 cytokines (i.e.,  I1-4 or 11-10) or antibodies neu- 
tralizing  Thl  cytokines  (i.e.,  anti-IFN-~/  or anti-TNF-ot 
antibodies)  reduces the magnitude of CHS  (6,  20-23).  Al- 
ternatively,  in vivo administration  of antibodies  neutraliz- 
ing Th2 cytokines (i.e.,  anti-II-4 or anti-II-10 antibodies) 
enhances  CHS  (20,  22).  Since these  results  suggested that 
CHS may be mediated by Thl  cells  and regulated by Th2 
cells,  we  examined  the  cytokines  produced  by  hapten- 
primed T  cells.  During initial experiments using antibody- 
mediated depletion of CD4 + or CD8 + T  cells in vivo, we 
observed results similar to Gocinski and Tigelaar (12), sug- 
gesting that the  elicitation  of CHS responses required im- 
mune CD8 + T  cells and that the magnitude of the response 
was regulated by CD4 + T  cells.  When the cytokines pro- 
duced by hapten-immune  CD4 + and  CD8 +  T  cells from 
either  dinitrofluorobenzene  (DNFB)-  or oxazolone  (Ox)- 
sensitized  mice  were  examined,  the  CD8 +  T  cells  pro- 
duced IFN-~/and no detectable I1-4 or I1-10, and the CD4 + 
T  cells produced I1-4 and/1-10 and little or no IFN-~/. These 
results expose the induction of two polarized and function- 
ally opposing populations of T  cells  by hapten sensitization 
to  induce  CHS:  IFN-~-producing  Tcl  CD8 +  T  cells  as 
the  effector  cells  of CHS  and  I1-4/II-10-producing Th2 
CD4 + T  cells that negatively regulate the response. The in- 
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duction of the Th2 regulatory, rather than a Thl  effector, 
population ofCD4 + T  cells demonstrates an important dis- 
tinction between CHS and classical  DTH reactions. 
Materials and Methods 
Mice.  BALB/c  and  C57B1/6  mice  were  obtained  through 
Dr. Clarence Reeder at the National Cancer Institute (Frederick, 
MD).  B10.D2 mice were purchased from The Jackson Labora- 
tory (Bar Harbor, ME). Adult females 6-10 wk of age were used 
throughout this study. 
Antibodies and Reagents,  The following mAbs were obtained 
from the American Type Culture  Collection  (Rockville, MD): 
GK1.5  (anti-mouse CD4),  MKD6  (anti-l-Aa),  14.4.4S  (anti-l- 
Ek/a), HB 102 (anti-Da); and HB159 (anti-Ka). mAbs from the cul- 
ture supernatant  of the IgG-producing hybridomas YTS 169.4.2.1 
(anti-mouse CD8 [24]), H57-597 (anti-TcR C[3 [25  D, and, KJ23a 
(Vi317a [26]), as well as those listed above, were purified by protein 
G chromatography. Capture and detection ofmAbs for cytokine- 
specific ELISA and recombinant cytokines for standardization  of 
assays were purchased from PharMingen (San Diego, CA). 
Sensitization and Elicitation of CHS.  Mice were sensitized  and 
challenged to elicit  CHS responses  to DNFB and Ox as previ- 
ously described  (27). For the induction of CHS to DNFB, groups 
of three mice were sensitized  by two daily paintings  (days 0 and 
+ 1) with 25 ~1 of 0.5% DNFB (Sigma Chemical Co., St. Louis, 
MO) on the shaved abdomen and 5 btl on the footpads.  For the 
induction  of CHS  to  Ox,  groups  of three  to  four mice  were 
painted on the shaved  abdomen once (day 0) with 50 ~1 of 3% 
Ox  (Aldrich  Chemical  Co.,  Milwaukee,  WI)  and  5  btl  on the 
footpads.  Sensitized  and unsensitized  control animals  were chal- 
lenged on day +5 by applying 10 ~1 of 0.2% DNFB or 1% Ox to 
each side of both ears. Increase  in ear swelling  (~) was measured 
in a blinded manner 24 h after challenge  with an engineer's mi- 
crometer (Mitutoyo Precision USA, Inc., Elk Grove Village, IL) 
and  expressed  in  units  of 10  -4 in as previously described  (27). 
The magnitude of ear swelling  (see Fig.  1) is given as the mean 
increase  of each group of three individual  animals  (i.e., six ears) 
minus the swelling in unsensitized  mice challenged with the hap- 
ten +  SEM. 
Antibody  Treatment  for Depletion of T Cells.  In vitro  depletion 
ofCD4  + or CD8 + T cells was performed by treatment with spe- 
cific antibody and complement. Briefly, lymph node cells (LNC) 
from hapten-sensitized  donors were suspended at  50  ￿  106/ml 
with  10 ~g/ml of GK1.5  (anti-CD4),  YTS  169  (anti-CDS),  or 
control (rat IgG) antibody in RPMI 1640. After 40 rain on ice, 
the cells were washed,  resuspended  at  10S/ml in rabbit  comple- 
ment  (Cedarlane  Laboratories  Ltd.,  Hornby,  Ontario,  Canada). 
After 45 rain at 37~  the cells were washed extensively  before 
use in culture.  In vivo, CD4 + or CD8 + T cells were depleted by 
intraperitoneal  injection of 100 p~g of YTS 169 (anti-CD8 mAb) 
or  GK1.5  (anti-CD4  mAb)  on  three  consecutive  days  as  de- 
scribed  by Cobbold and coworkers (24). This treatment resulted 
in depletion of ~96% of the target T  cell population as assessed 
by flow cytometry analysis (data  not shown).  Antibody-treated 
mice  were  rested  1-3  d  before  shaving and  sensitization  with 
DNFB or Ox. 
Isolation of Hapten-presenting Langerhans Cells (hpLC).  The  iso- 
lation of hpLC was performed using the protocol of Bigby and 
coworkers  (4). To isolate  DNFB hpLC,  mice were painted  on 
two consecutive days with 0.5% DNFB, and LNC were obtained 
20-24 h after the final painting.  To isolate Ox hpLC, mice were 
painted  once  with  3%  Ox,  and  LNC  were  obtained  20-24  h 
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6  ￿  106  cells/m1  in  complete  medium  (R.PMI  1640  supple- 
mented with 5 mM glutamine, 100 U/rnl penicillin-streptomycin, 
and 10% heat-inactivated FCS). The cell suspension (6-8 ml) was 
layered over 2 ml of 14.5% metrizamide (Sigma Chemical Co.) in 
PBS and centrifuged at 600 g for 10 min. The interface cells were 
collected and  washed  twice with  complete medium.  Consistent 
with  the  results  of Bigby  and  coworkers  (4),  microscopic  and 
flow cytometry examination of cells from the interface contained 
60-80% sIg-/class II MHC + cells with dendritic cell morphology. 
Cell Culture.  LNC were obtained either from unsensitized or 
from sensitized mice on day +4 and stimulated to produce cyto- 
kines by two different culture methods.  For stimulation by cul- 
ture  on antibody-coated  wells, 96 U-bottom-well tissue  culture 
plates were precoated with 30  Ixl/well of anti-TCR  (anti-TCR 
C[3,  H57-597,  or as a negative control, anti-V~17a,  KJ23a) anti- 
body at 25  Ixg/ml for 90 min at 37~  The wells were washed 
extensively, and 2  ￿  105 naive or hapten-irnmune LNC were de- 
livered to each well in 200 I~1 complete medium. After 48 h, cul- 
ture  supernatants  were  harvested  and  assayed  for cytokine  pro- 
duction by ELISA.  For stimulation  by culture with hpLC,  2  X 
105  naive  or  hapten-immune  LNC  were  cocultured  with  104 
hpLC,  unless  otherwise indicated,  in 200  ~l/well in 96  U-bot- 
tom-well  tissue  culture  plates.  Supernatants  were  harvested  and 
assayed for cytokine production 48 h later. In experiments deter- 
mining  the  role  of MHC  antigens  in  the  activation  of hapten- 
immune T  cells to produce cytokines, purified anti-class I MHC 
and/or anti-class II MHC antibodies were included in the cultures 
at 50 p,g/ml. 
ELISA.  Cytokine-specific sandwich  ELISA for determining 
quantities  of IFN-%  I1-2,  I1-4,  and  I1-10  were performed using 
capture and detection antibodies from PharMingen, generally fol- 
lowing the instructions  of the supplier.  For each antibody pair, 
the concentrations of capture and detection antibodies were opti- 
mized in initial experiments using recombinant cytokines. Briefly, 
polyvinyl chloride ELISA plates  (Dynatech Laboratories, Inc., Chan- 
tilly,  VA)  were  coated  with  antibodies  in  0.1  M  bicarbonate 
buffer,  pH  8.6,  during  overnight incubation  at  4~  The  plates 
were  washed  and  blocked  with  5%  FCS  plus  0.05%  gelatin  in 
PBS for 2  h  at 37~  After extensive washing,  duplicate aliquots 
of test supernatants  were delivered to the wells. All supernatants 
were tested undiluted and in at least 2-3 dilutions. Each plate also 
included 9-10 dilutions of the test recombinant cytokine as a pos- 
itive control and to obtain a standard curve for quantitation. After 
overnight incubation at 4~  each plate was washed extensively, 
and the biotin-labeled detection antibody was added. The plate was 
incubated for 1 h  at 37~  washed extensively, and streptavidin- 
alkaline-phosphatase  (Fisher Scientific Co., Pittsburgh,  PA) added. 
After a final incubation of 45 rain at 37~  each plate was washed 
and the assay developed by addition of the substrate, p-nitrophe- 
nyl phosphate  (Sigma Chemical Co.).  Results were read at 405 
nm using an automatic ELISA plate reader (Bio-Tek Instruments 
Inc., Winooski, VT) and mean values obtained.  The amount  of 
cytokine in each test supematant was calculated according to a stan- 
dard curve derived from the use of serially diluted recombinant cy- 
tokines performed in each plate. 
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antibodies to deplete CD4 + or CD8 § T  cells and then sen- 
sitized the animals for CHS with either DNFB  (Fig.  1 A) 
or Ox (Fig. 1 B). After hapten challenge to the ears, change 
in ear thickness was determined at 24-h increments for 5 d. 
Typical of CHS responses in this model, the magnitude of 
ear swelling in control antibody-treated animals rapidly de- 
creased from the peak observed at 24-48 h  after challenge 
and was at background levels by 72-96 h  after  challenge. 
The  effect  of anti-CD4  antibody  treatment  observed  in 
each  response  was  virtually  identical  in  that  depletion  of 
CD4 § T  cells resulted in a higher response than the control 
antibody-treated mice. In the absence ofCD4 + T  cells,  the 
DNFB  response  was  maintained  as  a  plateau  at  the  peak 
magnitude for 72 h  after challenge. Furthermore,  in CD4 + 
T  cell-depleted  animals,  the responses to both DNFB  and 
Ox decreased slowly and did not reach background levels 
until 120-192 h after challenge. Depletion ofCD8 + T  cells 
had  the  opposite  effect as  depletion  of CD4 §  T  cells,  re- 
sulting in a lower (40% of positive control) ear swelling re- 
sponse to Ox 24 h  after challenge and a more striking de- 
crease in the response to DNFB, lowering the response to 
background levels.  The low or absent  CHS responses  ob- 
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Results 
Increased and  Prolonged  CHS  Responses  in  the Absence  of 
CD4 + T  Cells.  To  begin  to  examine  the  roles  of CD4 § 
and CD8 +  T  cells in CHS, we treated BALB/c  mice with 
Hours Post-Challenge 
B 
Figure  1.  Contact  sensitivity  responses  in  the  absence  of CD4  §  or 
CD8  + T cells. BALB/c mice were given 100 p,g of rat IgG (IN) or anti- 
CD4 (EE) or anti-CD8 (X) mAb on three consecutive days. 2 d later, the 
animals were sensitized twice (days 0 and  +1) with 0.5% DNFB (A) or 
once (day 0) with 3% Ox (B). On day +5, each ear was challenged on 
both sides with 0.2% DNFB (A) or 1% Ox (B). The thickness ofhapten- 
challenged ears was measured at 24-h increments  and expressed as change 
(~) in ear swelling X  10 -4 in +  SEM when subtracted from swelling in 
unsensitized mice challenged with hapten. served in CD8 + T  cell-depleted  animals were maintained 
at  the  low levels for at least  120  h  after hapten  challenge 
(data not shown). These results confirm those originally re- 
ported by Gocinski andTigelaar (12)  and suggest that CD8 + 
T  cells mediate CHS responses, whereas CD4 + T  cells reg- 
ulate the magnitude of the response. 
Polarization  of Cytokine  Production  by  Immune  CD4 + and 
CD8 + T  Cells after Hapten Sensitization.  Since  the  results 
in Fig. 1 suggested that CD4 + and CD8 + T  cells may have 
different and possibly opposing functions during CHS, we 
examined the cytokines produced after in vitro stimulation 
of CD4 § and CD8 + T  cells from DNFB- or Ox-sensitized 
mice.  The  first  approach  taken  was  to  stimulate  hapten- 
immune LNC by culture with anti-TCR, antibody-coated 
wells and test the culture supernatants for cytokine produc- 
tion  by  ELISA.  In  preliminary  experiments,  culture  of 
DNFB-  or Ox-immune  LNC with  either  anti-TCR  C]3 
antibody H57-597 or anti-CD3e antibody stimulated simi- 
lar and detectable levels ofcytokines in the supematant 48 h 
after culture initiation  (data not shown). Cytokine produc- 
tion  was  not stimulated  either  during  culture  of immune 
LNC  on  control  anti-TCR  (i.e.,  anti-V[317a)  antibody- 
coated wells  or during culture  of LNC from unsensitized 
mice on H57-597 (data not shown). Whereas H57-597 stim- 
ulation of Ox-immune cells from control antibody-treated 
mice resulted in the production of low but detectable levels 
of I1-2, I1-4, and IFN-~/and higher levels of I1-10, stimula- 
tion  of Ox-immune  LNC  from anti-CD4  and  anti-CD8 
antibody-pretreated animals revealed a polarized pattern of 
cytokine production (Fig. 2 A). Immune (CD8 +) cells from 
anti-CD4 antibody-treated animals produced higher levels 
of IFN-~ than immune cells from control antibody-treated 
mice but  nondetectable  levels  of I1-2,  I1-4,  and  I1-10.  In 
contrast,  immune  (CD4 §  cells  from anti-CD8  antibody- 
treated  animals  produced  higher  levels  of I1-2,  I1-4,  and 
I1-10  than  the  control  and  a  barely  detectable  level  of 
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Figure  2.  Anti-TCR antibody-stim- 
ulated  cytokine production  by  LNC 
from  hapten-sensitized mice. BALB/c 
mice were given 100 p,g of rat IgG (Im- 
mune  T  Cells) or  anti-CD4  (Immune 
CD8  +  Cells)  or  anti-CD8  (Immune 
CD4  + Cells) mAb on three consecutive 
days. 2 d later, the animals were sensi- 
tized once (day 0) with 3% Ox (A) or 
twice (days 0 and + 1) with 0.5% DNFB 
(B). On day +4, LNC suspensions from 
sensitized or unsensitized (Naive T Cells) 
animals were prepared, and 2 ￿  10  s cells 
were  cultured on  anti-TCR  antibody 
(H57-597)-coated  wells.  Supernatants 
were collected 48 h later and analyzed 
by ELISA for quantity of the indicated 
cytokine. ND, not detectable. 
1004  Polarized Cytokine Production by Hapten-primed CD4 + and CD8  + T Cells IFN-~/. As indicated above, stimulation of LNC from un- 
sensitized animals did not result in 11-4, 11-10, and IFN-'y 
production,  although very low amounts  of I1-2 were de- 
tected in a few experiments. 
The distinct patterns  of cytokine production by CD4 + 
and CD8 + T  cells  were also observed after stimulation of 
immune LNC from DNFB-sensitized mice pretreated with 
anti-CD8  or  anti-CD4  antibodies.  Similar  to  results  ob- 
served with Ox-immune cells, DNFB-immune (CD8 +) cells 
from anti-CD4 antibody-treated mice produced high lev- 
els of IFN-~/and no II-2 or I1-4 after stimulation with the 
anti-TCR antibody, and (CD4 +) cells from mice pretreated 
with anti-CD8 antibody produced II-2 and I1-4 but barely 
detectable amounts of IFN-'y (Fig. 2  B).  In contrast to the 
Ox-immune  CD4 +  T  cells,  production  of I1-10  by  the 
DNFB-immune cells from anti-CD8 antibody-treated mice 
was  undetectable.  In  addition,  the  quantity  of I1-4  pro- 
duced by DNFB-immune CD4 + T  cells after H57 stimula- 
tion was always considerably lower when compared with 
the amount produced by Ox-immune CD4 § T  cells (e.g., 
212 pg/ml for Ox vs. 77 pg/ml for DNFB). 
To ensure that the patterns of cytokine production ob- 
served were not a  trivial effect attributable  to the in vivo 
antibody-mediated depletion of CD4 + and CD8 + T  cells, 
the  cytokines  produced  by  immune  LNC  depleted  of 
CD4 +  or CD8 + T  cells in vitro was assessed.  Aliquots of 
LNC from Ox-sensitized mice were treated with control, 
anti-CD4,  or anti-CD8  antibody and  complement. After 
washing, the cells were cultured on H57-597-coated wells 
and  the  supematants  analyzed by ELISA 48  h  later.  Im- 
mune  cells  treated  with  control  (rat  IgG)  antibody  and 
complement produced detectable levels of I1-4,  I1-10,  and 
IFN-~/  after culture  on  anti-TCP,  antibody-coated wells 
(Fig.  3).  As  observed in  the  previous  experiment,  naive 
LNC did not produce I1-4 or I1-10 during culture on anti- 
TCtL antibody, although a small amount of IFN-~/was de- 
tected. Depletion of CD4 § T  cells from the immune cells 
removed cells producing I1-4 and I1-10,  whereas cells pro- 
ducing IFN-~/remained. Depletion of CD8 + T  cells from 
the immune population did not affect cells producing I1-4 
and  I1-10 but  reduced  IFN-~/ production  to  background 
levels. Collectively, the results shown in Figs. 2 and 3 indi- 
cated a segregated pattern of cytokine production by hap- 
ten-senstized  T  cells  with  immune  CD8 +  T  (Tcl)  cells 
producing  IFN-~/ and immune CD4 +  T  (Th2)  cells  pro- 
ducing I1-2, 11-4, and I1-10. 
Hapten-immune  T  Cell  Cytokine  Production  Stimulated  by 
hpLC.  Whereas anti-TcP, antibody was shown to stimu- 
late cytokine production by immune CD4 + and CD8 + T 
cells  from hapten-sensitized mice,  activation of T  cells  is 
normally  mediated  by  cellular  presentation  of anfigen- 
MHC  complexes. The hapten-presenting cells  priming T 
cell responses in CHS are LC, which migrate from the sen- 
sitized  epidermis to  the  skin-draining lymph nodes  (3-5, 
28).  To examine hapten-primed CD4 + and CD8 + T  cell 
cytokine production using a more physiological system, we 
isolated  semipurified  LC  from the  lymph  nodes  of mice 
24 h  after painting with Ox as described in Materials and 
Methods  and  tested  the  ability of the  hpLC  to  stimulate 
I1-4  and  IFN-~/  production  by  Ox-immune  LNC  from 
mice  pretreated  with  anti-CD4  or  anti-CD8  antibodies. 
The  amount  of 11-4 produced  by Ox-immune  CD4  +  T 
cells  (from  CD8-deleted  animals)  during  coculture  with 
Ox hpLC was dependent on the number of LC in the cul- 
ture (Fig.  4). Detectable levels of II-4 were observed when 
as few as 5,000 hpLC were cultured with the immune CD4 + 
T  cells.  Similarly,  production  of IFN-~/ by Ox-immune 
CD8 + T  cells was dependent on the number of LC added 
to the culture with detectable cytokine stimulated by as few 
as 2,500 LC. 
Although  the  quantifies  produced  were  considerably 
lower than those  observed after stimulation by anti-TCR. 
antibody,  the  hpLC  stimulated  immune  LNC  from Ox- 
sensitized  mice pretreated  with  control  antibody  to  pro- 
duce I1-2,  I1-4, and IFN-~/ (Fig.  5 A). LNC from unsensi- 
tized mice were not stimulated to produce detectable levels 
of cytokines during culture with the hpLC. Immune lymph 
node CD8 + T  cells from animals pretreated with anti-CD4 
antibody  produced  increased  amounts  of IFN-~/  (when 
compared with the  cells  from the  control immune mice) 
and no I1-2 or I1-4 during coculture with the hpLC.  Im- 
mune CD4 + T  cells from anfi-CD8 antibody-treated mice 
Naive 
T Ceils 
immune 
T C~ls 
~mmune 
CD$  + Ceils 
|mmol'lm 
CD4  + Cds 
Conoentra~on (pg/ml)  Conoentratlon (nghnl) 
0  100  200  300  400  0  1  2  3  4  0 
!  IL4  IL-IO 
NO  ND 
NO 
Concentration (ng/mi) 
100  :,00  300  400 
m 
! 
Figure  3.  Cytokine  production  by  Ox- 
immune CD4 + and CD8 + T  cells. BALB/c 
mice were sensitized once with 3% Ox, and 
4 d later LNC suspensions were prepared 
and  treated first with anti-CD4  (Immune 
CD8 + Cells) or anti-CD8 (Immune CD4 + 
Cells) antibody and then with complement. 
Control (Immune T Cells) cells were treated 
with complement  only. After washing, 2 ￿ 
10  s  treated immune or  nontreated naive 
cells were cultured on anti-TCP, antibody 
(H57-597)-coated wells. Supematants were 
collected 48 h later and analyzed  by ELISA 
for quantity of the indicated cytokine. ND, 
not detectable. 
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ing  culture  of the  Ox-immune  cells  with  hpLC  isolated 
from DNFB-sensitized mice (Table  1).  Similarly,  immune 
CD4 + and CD8 + T  cells from DNFB-sensitized mice pro- 
duced detectable  amounts of I1-4 and IFN-% respectively, 
during culture with hpLC from DNFB-sensitized mice but 
not during culture with hpLC isolated from Ox-sensitized 
mice. 
The ability of anti-class I MHC  and anti-class II MHC 
antibodies  to  inhibit  the  hpLC-stimulated  production  of 
cytokines by hapten-immune CD4 + and CD8 § T  cells was 
12o  examined.  Immune  LNC  from  Ox-sensitized  mice  pre- 
treated  with  either  anti-CD4  or anti-CD8  antibody were 
cultured with hpLC from Ox-sensitized mice in the pres- 
ence of antibodies specific for class I MHC  (K  a, HB159, or 
D d,  HB102)  or  class  II  MHC  (I-A  d,  MKD6,  or  I-E  k/d, 
14.4.4S).  Supematants  were  harvested  48  h  after  culture 
initiation and the quantities of IFN-'f and I1-4 were deter- 
mined  (Table  2).  Consistent  with  the  observations in this 
report,  immune  T  cells  from  anti-CD4  antibody-treated 
animals were stimulated to produce IFN-~/and no detect- 
able  I1-4  during  culture  with  hpLC,  whereas  immune  T 
cells from anti-CD8  antibody-treated animals were stimu- 
lated  to produce  I1-4 and barely  detectable  IFN-~/ during 
the culture.  The presence of anti-class II MHC  antibodies 
in the culture had virtually no effect on the production of 
IFN-~/ by the  immune  CD8 +  T  ceils.  IFN-'v production 
was inhibited in the presence of either anti-K  a (55% inhibi- 
tion)  or anti-D  a  (40%  inhibition)  antibodies.  This  inhibi- 
tion was never complete, however, even when the anti-K  d 
and anti-D a antibodies were used in combination. Produc- 
tion of I1-4 by the immune CD4 + T  cells  (i.e.,  from anti- 
CD8 antibody-treated animals)  during culture with the hpLC 
was  completely blocked in  the  presence  of anti-I-E  anti- 
body but was only partially blocked (44% inhibition)  in the 
presence  of the  I-A antibody.  Although the  hpLC-stimu- 
lated production of I1-4 by immune CD4 + T  cells was not 
inhibited by the  anti-K  a antibody,  addition  of the  anti-D  d 
antibody to the culture consistently resulted in lower (30- 
43% inhibition)  quantities of I1-4 produced by the CD4 + T 
cells.  Reasons for the low level of inhibition  by this  anti- 
body are unclear at this time. These results indicate that the 
immune T  cells from hapten-sensitized mice have conven- 
tional  MHC  restriction  patterns  for activation  in  that  the 
CD4 +  Th2  cell production  of I1-4 is restricted  to  class  II 
MHC,  and the CD8 + Tcl  cell production of IFN-~/is,  at 
least partially, restricted to class I MHC. 
Induction  of Polarized  Responses  in  BIO.D2  and  C57B1/6 
Mice.  In several model systems, BALB/c mice have a ten- 
dency to mount a Th2 rather than a Thl  response  to test 
antigens  (29,  30).  To  determine  the  induction  of  Tcl 
CD8 + T  cells and Th2 CD4 + T  cells after hapten sensitiza- 
tion  in  other strains  of mice,  we  examined  the  cytokine- 
producing phenotypes of T  cells  in C57B1/6  and B10.D2 
mice. Groups of mice were treated with control, anti-CD4, 
or anti-CD8 antibodies and sensitized with Ox. As observed 
with  cells  from BALB/c  mice,  LNC  from Ox-sensitized 
C57B1/6 (Fig. 6 A) and B10.D2  (Fig. 6 B) mice pretreated 
with control antibody produced readily detectable amounts 
Polarized Cytokine Production by Hapten-primed CD4 + and CD8 + T Cells 
Figure  4. 
--*--  Immune CD4+  Cells 
Immune CD8+  Cells 
zo  40  so  ao  loo  12o 
hpLC  Number  (X  lO0)/Well 
hpLC  stimulate immune  T  cells to  produce  cytokines. 
BALB/c mice were given 100 }xg of anti-CD4 (Immune CD8  § Cells) or 
anti-CD8 (Immune CD4  + Cells) mAb on three consecutive days. 2 d later, 
the animals were sensitized once with 3% Ox. 4 d later, LNC suspensions 
were prepared, and 2 X 10  s cells were cultured with the indicated num- 
ber of semipurified hpLC from Ox-sensitized mice. The hpLC were iso- 
lated from LNC suspensions 24 h after Ox painting by metrizamide gradi- 
ent centrifugation. Culture supernatants were collected 48 h later and 
analyzed by ELISA  for quantity of IFN-"/and II-4. 
produced increased amounts of I1-2 or I1-4 and barely de- 
tectable  amounts  of  IFN-"/  during  coculture  with  the 
hpLC,  In contrast  to  culture  on anti-TCR-coated  wells, 
the  production  of I1-10  during  culture  of immune  LNC 
with  the  hpLC  was  never  observed  during  the  course  of 
these experiments. 
When  semipurified  LC  from DNFB-sensitized  animals 
were  tested  for  the  ability  to  stimulate  DNFB-immune 
LNC  to  produce  cytokines,  similar  results  to  the  Ox  re- 
sponse were observed. Culture of immune LNC from anti- 
CD8  antibody-treated  mice  produced  higher  amounts  of 
I1-4 than immune cells from control antibody-treated mice 
during  culture  with  hpLC,  and  immune  LNC from anti- 
CD4  antibody-treated  mice produced  higher  amounts  of 
IFN-~/  than  the  nondeleted  control  immune  cells  (Fig.  5 
B).  The  quantities  of I1-4  and  IFN-~/  produced  by  the 
DNFB-immune LNC during culture with the hpLC were 
consistently lower than the  amounts produced during co- 
culture of Ox-immune LNC and Ox-presenting LC. 
The ability of the hpLC to stimulate CD4 § and CD8 + T 
cells to produce cytokines in a hapten-specific manner was 
then examined. Whereas immune CD4 + and CD8 + T  cells 
from Ox-sensitized  mice produced  the  segregated pattern 
of cytokines during culture with hpLC isolated from Ox- 
sensitized mice, cytokine production was undetectable dur- 
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Figure 5.  bpLC stimulate immune CD4 + and CD8 + T cells 
to produce the polarized pattern of cytokines.  BALB/c mice 
were given 100 ~g of rat IgG (Immune T  Cells) or anti-CD4 
(Immune CD8  § Cells) or anti-CD8 (Immune CD4  + Cells) mAb 
on three consecutive days. 2  d later,  the animals were sensi- 
tized once (day 0) with 3% Ox (A) or twice (days 0 and + 1) 
with 0.5%  DNFB  (B). On  day  +4,  LNC  suspensions  from 
sensitized  or unsensitized (Naive  T  Cells) animals  were pre- 
pared,  and 2 X 10  s cells were cultured with 104 hpLC isolated 
from lymph nodes 24 h after painting with Ox (A) or DNFB 
(B).  Supematants were  collected 48 h  later and analyzed  by 
ELISA for quantity of the indicated cytokine. ND,  not de- 
tectable. 
of I1-4,  I1-10,  and  IFN-~/  after  stimulation  with  H57.  In 
each of the tested strains of mice,  deletion of CD4 +  T  cells 
before sensitization resulted in increased IFN-~/production 
but no detectable 11-4 or I1-10 during the culture with anti- 
TCR  antibody.  Deletion  of CD8 +  T  cells  resulted  in in- 
creased I1-4 and I1-10 production  while virtually eliminat- 
ing  the  production  of IFN-2~.  These  results  indicate  that 
the induction of polarized populations of IFN-~/producing 
Table 1.  Stimulation of Pn'med  T  Cell Cytokine Production  by hpLC Is Hapten Specific 
Cytokine production induced by 
Ox-hpLC  DNFB-hpLC  H57 
mAb pretreatment  Hapten sensitization  IFN-~/  I1-4  IFN-~/  I1-4  IFN-~/  I1-4 
None  None  ND  ND  ND  ND  ND  ND 
None  Ox  5.6  22  ND  ND  180  225 
Anti-CD4  Ox  7.6  ND  ND  ND  387  ND 
Anti-CD8  Ox  ND  81  ND  ND  6  703 
None  DNFB  ND  ND  2.6  16  62  38 
Anti-CD4  DNFB  ND  ND  8.6  ND  200  ND 
Anti-CD8  DNFB  ND  ND  ND  33  30  77 
BALB/c mice were given 100 I~g of rat IgG (None) or anti-CD4 or anti-CD8 mAb on three consecutive days. 2 d later, the animals were sensitized 
once (day 0) with 3% Ox or twice (day 0 and + 1) with 0.5% DNFB. On day 14, LNC suspensions from sensitized or unsensitized animals were pre- 
pared, and 2  ￿  105 cells were cultured either with 104 hpLC isolated from lymph nodes 24 h after painting with Ox or DNFB or on anti-TCR an- 
tibody (H57-597)-coated wells.  Supernatants were collected 48 h later and analyzed by ELISA for quantity of the indicated cytokine. The unit for 
IFN-~/is nanograms per milliliter and for ]L4 is picograms per milliliter. 
ND, not detectable. 
1007  Xu et al. Table 2.  Inhibition  of Hapten-primed T Cell Cytokine Production 
by Anti-MHC Class I or Class II Antibodies 
mAb pretreatment  mAb in the culture  IFN-~  I1-4 
Anti-CD4 
Anti-CD8 
None 
Anti-K  d 
Anti-I-A  a 
Anti-D  a 
Anti-l-E  km 
Anti-K  a +  anti-D  a 
None 
Anti-K  a 
Anti-I-A  a 
Anti-D  a 
Anti-l-E  k/a 
Anti-I-A  a +  anti-I-E  k/d 
abrogation of the response to DNFB and a 40-80% reduc- 
tion in the response to Ox (Fig.  1).  These results  confirm 
experiments  and resuks reported by Gocinski and Tigelaar 
(12).  Furthermore,  these  investigators  demonstrated  that 
depletion  of CD4 +  T  cells from immune LNC  enhanced 
(ng/ml)  (pg/ml)  the passive transfer of the CHS response to DNFB, whereas 
11.6  ND  depletion  of CD8 +  T  cells abrogated the  transfer of CHS 
5.2  ND  (12).  These results are contrary to studies  of other investi- 
10.1  ND  gators indicating that CD4 +, and not CD8 +, T  cells medi- 
ate CHS (8, 9). This discrepency may be due to inefficient  7.0  ND 
10.0  ND  antibody-mediated depletion  of CD8 + T  cells in the latter 
studies.  In  support  of the  proposed  roles  of CD4 +  and 
6.7  ND  CD8 +  T  cells in CHS are recent results from this labora- 
1.8  120  tory  examining  the  CD4 +  and  CD8 +  T  cell-dependent 
1.0  120  expression  of proinflarnmatory  cytokine  (i.e.,  chemokine) 
2.1  68  genes during the elicitation of CHS in which we observed 
1.9  81  that  expression  of  an  IFN-~/-induced  chemokine  gene 
ND  ND  (IP-10) was mediated by immune CD8 + T  cells (Abe, M., 
ND  ND  T. Kondo, H. Xu, and R.L. Fairchild, manuscript submit- 
ted  for  publication).  Moreover,  the  expression  of IP-10 
during CHS was amplified in the absence of CD4 + T  cells 
and was inhibited by the  activity of CD4 +  T  cells.  These 
results suggested that IFN-~/production in CHS was medi- 
ated by CD8 + T  cells  and that CD4 §  T  cells may inhibit 
IFN-',/production or its downstream effects. 
The  effector  role  of CD8 §  T  cells  and  the  regulatory 
role of CD4 + T  cells in CHS are supported by the polar- 
ized pattern of cytokines produced by each T  cell popula- 
tion.  Sensitization with either DNFB or Ox induced both 
hapten-specific CD8 + T  cells producing IFN-~/and no I1-4 
or I1-10, and hapten-specific CD4 + T  cells producing II-4 
and I1-10 and no or litde IFN-~. Anti-TCP.. antibody acti- 
vation of Ox- and DNFB-immune CD4 + T  cells also stim- 
ulated  production  of  the  Th2  cytokine  I1-5  (data  not 
shown).  In addition  to  the  Th2  cytokines,  stimulation  of 
the  CD4 +  T  cells  resulted  in I1-2 production.  This  could 
indicate  either the  ability of the hapten-immune  CD4 + T 
cells  to produce  I1-2 in  addition  to  Th2  cytokines or the 
presence  of two  distinct  populations  of hapten-immune 
CD4 +  T  cells,  an  undifferentiated  population  (e.g.,  Th0) 
producing I1-2 and a Th2 population producing 11-4, 11-5, 
and I1-10. Experiments  to distinguish  these possibilities  are 
currently in progress. The role of IFN-~ as one of the ma- 
jor cytokine mediators  of CHS and the  ability of I1-4 and 
I1-10 to inhibit  CHS responses have been well established 
(6, 7, 20-23). The direct role of I1-4 in regulating CHS has 
been further suggested in studies by Gautam and co-work- 
ers  (20)  in which  anti-II-4 antibody given  at  the  time  of 
hapten  challenge,  but  not  sensitization,  resulted  in  re- 
sponses  of increased magnitude.  In contrast,  we have  ob- 
served that anti-I1-4 antibody given during hapten sensiti- 
zation  also  resulted  in  increased  CHS  responses  (Xu,  H., 
unpublished  observations).  Since the induction of Th2 re- 
sponses has been shown to be dependent on I1-4 (34-36), it 
is  tempting to speculate  that  neutralization  of I1-4 during 
sensitization  may  inhibit  the  development  of the  CD4 + 
Th2  regulatory population  during sensitization  and subse- 
quently result in increased CHS responses. 
Polarized Cytokine Production by Hapten-primed CD4 + and CD8 + T Cells 
BALB/c mice were given 100 I~g of anti-CD4  or anti-CD8 mAb on 
three consecutive days. 2 d later, the animals were sensitized once, (day 
0) with 3% Ox. On day +4, LNC suspensions from sensitized animals 
were prepared, and 2 ￿  105 cells were cultured with 104 hpLC isolated 
from lymph nodes 24 h after painting with OX in the presence of the 
indicated anti-MHC  antibodies at 50  ~l/ml.  Supernatants were col- 
lected 48 h later and analyzed by ELISA  for quantity of the indicated 
cytokine. 
ND, not detectable. 
Tcl CD8 + and I1-4/II-10-producing Th2 CD4 + T  cells in 
CHS is not restricted to BALB/c mice. 
Discussion 
Although  the  elicitation  of  CHS  responses  has  been 
shown to be dependent on the activity ofhapten-specific T 
cells, the requirement for and the roles ofCD4 + and CD8 + 
T  cells  in  CHS  have  remained  unclear.  Whereas  in vivo 
and in vitro antibody depletion studies from several labora- 
tories have indicated CD4 + T  cells as the effector T  cells in 
CHS,  others have observed the ability of CD8 + T  cells to 
mediate CHS (8,  9, 12). The isolation ofurushiol-reactive, 
IFN-~/-producing CD8 +  T  cells  from the  skin  lesions  of 
patients  sensitized  to poison ivy is supportive  of the  pro- 
posed effector role of CD8 + T  cells in CHS  (31).  In sup- 
port of the  role of CD4 + T  cells as the  effectors of CHS, 
the characterization of CD4 + T  cell clones from the lesions 
of patients with allergic contact dermititis to nickel and co- 
balt has been reported (32, 33). 
The results  of this study clearly demonstrate  the induc- 
tion of both CD4 + and CD8 + T  cells during hapten sensi- 
tization and distinguish the role of each population during 
the  elicitation  of the  CHS  response.  Antibody-mediated 
depletion  of CD4 +  T  cells before hapten sensitization  re- 
suited in prolonged CHS responses of increased magnitude, 
whereas  depletion  of CD8 +  T  cells  resulted  in  complete 
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Figure 6.  Hapten sensitization induces polarized 
patterns  of  cytokine  production  by  CD4  +  and 
CD8 +  T  cells  in  C57B1/6  and  B10.BR  mice. 
C57B1/6 (A) or B10.B1L (B) mice were given 100 
~g of rat IgG  (Immune  T  Cells)  or anti-CD4  (Im- 
mune  CD8 +  Cells)  or  anti-CD8  (Immune  CD4 + 
Cells) mAb on three consecutive days. 2 d later, the 
animals were sensitized once with 3% Ox. 4 d later, 
LNC  suspensions from  sensitized  or  unsensitized 
(Naive T  Cells) animals were prepared, and 2  ￿  105 
cells were cultured on anti-TCR antibody (1-157- 
597)-coated wells. Supernatants were collected 48 h 
later and analyzed by ELISA for quantity of the in- 
dicated cytokine. ND, not detectable. 
The  polarized  cytokine  patterns  produced  by  hapten- 
primed  CD4 +  and  CD8 +  T  cells  were revealed through 
stimulation with either anti-TCR antibody or hpLC. The 
quantities of IFN-~/and I1-4 produced by hapten-immune 
CD8 + and CD4 + T  cells,  respectively, were higher in the 
absence of the reciprocal T  cell population, suggesting a de- 
gree of  cross-regulation. Whereas readily detectable amounts 
of I1-10  were  stimulated  during  culture  of Ox-immune 
CD4 + T  cells on anti-TCR antibody, detectable I1-10 was 
not produced during culture of the cells with hpLC.  It is 
possible that production ofll-10 by hapten-sensitized CD4 + 
T  cells  requires a  strong TCR-mediated activation signal 
that is provided by the anti-TCR, antibody but not by the 
hpLC. This differential production of ll-10 by the hapten- 
primed  CD4 +  T  cells  could indicate  that  CD4 +  T  cells 
produce I1-4 but not I1-10 during the CHS response. Sev- 
eral observations support the hypothesis that II-10--medi- 
ated inhibition of  CHS may be the result of  innate or non-T 
cell immune mechanisms.  First,  studies  by Enk and Katz 
(37) have indicated that hapten sensitization stimulates ke- 
ratinocytes to  produce  I1-10.  Second,  Ferguson  and  co- 
workers  (22)  have  reported  that  the  highest  amount  of 
11-10 protein in  the  hapten-challenged tissue  of immune 
mice was detected at 10-14 h after challenge, which is sev- 
eral hours before the peak magnitude of the CHS response. 
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Furthermore,  the  quantity  of II-10  in  the  hapten-chal- 
lenged ear tissue of naive and sensitized mice was the same 
(Ferguson, T., personal communication). In light of these 
results,  CD4 + T cell regulation of CHS, as demonstrated in 
this and other reports (12), may be mediated through the 
production of I1-4. This is difficult to reconcile with recent 
results  from Berg and  coworkers  (38)  indicating  normal 
CHS responses to Ox in mice with targeted disruption of 
the I1-4 gene but enhanced responses in mice with targeted 
disruption of the I1-10 gene. 
A  critical factor influencing CD4 + T  cell development 
to the Thl or Th2 phenotype is the cytokine environment 
during T cell encounter with APC. The generation of Th2 
CD4 +  T  cells  requires  11-4 in  the  priming  environment 
(34--36), whereas APC production of I1-12 skews CD4 § T 
cells to the Thl phenotype (39, 40).  The hapten-present- 
ing cells priming T  cell responses in CHS are LC, which 
migrate from the sensitized epidermis to the skin-draining 
lymph nodes (3-5). The induction of the Th2, rather than 
a Thl, CD4 + T  cell population in CHS suggests  that the 
hapten-presenting LC do not produce I1-12 during priming 
of the CD4 + T  cells. This prediction is consistent with the 
observed production of I1-10 by keratinocytes after hapten 
sensitization and the ability ofll-10-treated LC to stimulate 
the activation ofTh2 CD4 + T  cells but not Thl cells (37, 41).  Furthermore,  results from D'Andrea et al.  (42)  have 
clearly shown  the  ability of I1-10  to inhibit  mononuclear 
cell production ofi1-12. Thus, the I1-10 produced by kera- 
tinocytes after hapten sensitization may render the LC inca- 
pable of producing I1-12 and unable to promote the induc- 
tion  of hapten-specific Thl  CD4 +  T  cells.  We have not 
addressed this issue  directly but have recently tested the ef- 
fect of exogenous I1-12  on the CHS response. The results 
have indicated  that  administration  of I1-12  during  hapten 
sensitization abrogates the induction of the I1-4--producing 
Th2  cells  and instead induces  an IFN-~/-producing (Thl) 
CD4 + T  cell population (DiIulio, N.A., H. Xu, and R.L. 
Fairchild,  manuscript in preparation).  This results in CHS 
responses  with  greater magnitude  and  prolonged  kinetics 
than control responses, very similar to the  response when 
the  CD4 +  (Th2)  regulatory cell population is  absent.  Al- 
though these observations are consistent with the hypothe- 
sis that LC do not produce I1-12 during the priming of the 
CD4 + T  cell population in CHS, the ability of LC to pro- 
duce I1-12 after culture and/or stimulation in vitro or dur- 
ing other types of immune responses may differ from LC in 
CHS.  Recently,  Rook  and  coworkers  (43)  reported  that 
stimulation of isolated LC with retinoic acid during over- 
night  culture  resulted  in  the  production  and  secretion  of 
the 11-12 heterodimer. 
Although  the segregated patterns of cytokine produced 
by hapten-primed CD4 +  and CD8 + T  cells  in  this study 
were  virtually  absolute,  in  many instances  stimulation  of 
CD8-deleted immune LNC resuked in the production of 
very small amounts of IFN-~/. At the present time it is not 
known if hapten-immune CD4 + T  cells  are the source of 
this  IFN-~/.  The  administration  of  anti-CD8  antibody, 
YTS 169, results in >96% deletion of CD8 + T  cells in our 
hands,  and  it  is  unlikely  that  the  few  remaining,  if any, 
CD8 + T  cells make quantities of IFN-~/that are above the 
level  of detection  in  the  ELISA.  It is possible that  other 
cells, such as NKI.1 cells, produce IFN-',/after sensitization 
and may be the source of these small amounts of IFN-y. A 
role for NKI.1 + cells in producing cytokines such as IFN-~/ 
and I1-4 to promote the generation of Thl  or Th2 CD4 + 
T  cell responses has been recently proposed and is under 
intensive study in several laboratories (44,  45). 
Collectively, the results of this report have exposed the 
induction  of two cellular components participating in the 
CHS response. The effector cells in the response are CD8 + 
T  (Tcl) cells producing IFN-% whereas I1-4/II-10-produc- 
ing CD4 + T  (Th2)  cells function as negative regulators of 
the response.  These results distinguish  CHS from classical 
DTH  responses,  which  are  primarily,  though  not  exclu- 
sively, mediated by IFN-~-producing CD4 + (Thl) T  cells 
(10,  11).  Studies  in experimental murine  cutaneous leish- 
maniasis have demonstrated the resistance of C57B1/6 mice 
to infection through the ability to mount a Thl  CD4 + T 
cell-mediated DTH response and clear the infection  (29). 
Infection is lethal in BALB/c  mice, which  mount  a Th2 
CD4 + response incapable of clearing the parasite load.  In 
contrast to the  disparate induction  of Thl/Th2  responses 
to these parasite antigens, the induction of the effector CD8 + 
and regulatory CD4 + T  cells in CHS does not appear to be 
dependent  on the genetic background of the mouse strain 
under study. Hapten sensitization of C57B1/6 and B10.D2 
mice resulted in the generation of the Tcl and Th2 popu- 
lations of cytokine-producing cells.  The induction of both 
of these cell populations during CHS results in an effector/ 
regulatory balance with the Th2 CD4 + T  cells providing a 
protective role by dampening the response and preventing 
overt immunopathology during the CHS response, Disrup- 
tion of the balance between the CD4 + and CD8 + T  cells 
through  either  inhibition  or  deletion  of the  Th2  CD4 + 
regulatory population would be predicted to result in ex- 
tended immunopathology during the immune response to 
hapten-altered self-determinants, The delineation of the el- 
lector and regulatory mechanisms in CHS should provide 
the  ability to skew the balance therapeutically in favor of 
the regulatory T  cell population and control the magnitude 
and duration of the CHS response. 
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